Pasquel et al. evaluated a group of 279 hospitalized patients with type 2 diabetes, using oral medications or insulin up to a total dose of 0.6 IU/kg/day and blood glucose levels below 400 mg/dL, in a multicenter randomized study. This evidence concerns the gene INS and type 2 diabetes mellitus.